Neurofeedback Versus Pharmacological Intervention in the Treatment of Childhood Attention Deficit/Hyperactivity Disorder (ADHD): First Spanish Clinical Neuropsychological Study

Denise Medici; Pau Giner Bayarri; Rosa Chilet Chilet; Juan Moliner Ibánez; Maria Morales Suarez-Varela; Dayana Calvo

doi:doi:10.11648/j.ajap.20180705.11

| Peer-Reviewed

Neurofeedback Versus Pharmacological Intervention in the Treatment of Childhood Attention Deficit/Hyperactivity Disorder (ADHD): First Spanish Clinical Neuropsychological Study

Denise Medici, Pau Giner Bayarri, Rosa Chilet Chilet, Juan Moliner Ibánez, Maria Morales Suarez-Varela, Dayana Calvo

Published in American Journal of Applied Psychology (Volume 7, Issue 5)

Received: 3 October 2018 Accepted: 6 November 2018 Published: 18 December 2018

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

In this study, twenty children diagnosed with ADHD according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria (DSM-IV) were randomly assigned to receive NFB training or MPH treatment. The participants were evaluated at the beginning of the study and four months later on measures of behavioral (CPRS/CPRT), executive functions (BRIEF, CPT), attention (TOVA), and electrical activity (qEEG, ERPs). Post-intervention results showed improvements in attention, hyperactivity, executive functioning and in continuous performance measurement (CPT).Improvements noted in the NFB group were greater than that of the MPH group. Results of this study suggest NFB training resulted in greater improvements in executive functioning, behavior, attention, and qEEG compared to MPH treatment. Results indicate that neurofeedback may treatcognitive and behavior functions before these functions worsen or decrease. This study suggests future research to compare the efficacy of each of these treatments in larger populations with a greater heterogeneity in gender is warranted.

Published in	American Journal of Applied Psychology (Volume 7, Issue 5)
DOI	10.11648/j.ajap.20180705.11
Page(s)	57-66
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

ADHD, Quantitative Electroencephalogram, Event-related Potentials, Continuous Performance Test, Neurofeedback, Methylphenidate

References

[1]	Polanczyk, G., de Lima M. S., Horta, B. L., Biederman, J., & Rohde, L. A. (2007). The worldwide prevalence of ADHD: a systematic review and meta-regression analysis. Am J Psychiatry; 164(6): 942–94. https://ajp.psychiatryonline.org/doi/abs/10.1176/ajp.2007.164.6.942.
[2]	Mehta, M. A., Goodyer, I. M., & Sahakian, B. J. (2004). Methylphenidate improves working memory and set-shifting in AD/HD: Relationships to baseline memory capacity. J Child Psychol Psychiatry, 45: 293–305.
[3]	Klassen, A. F., Miller, A. R., & Fine, S. (2004). Health related quality of life in children and adolescent who have a diagnosis of attention-deficit/hyperactivity disorder. Pediatrics, 114, 541-547. http://dx.doi.org/ 10.1542/peds.2004-0844.
[4]	Monastra, V. J., Lynn, S., Linden, M., Lubar, J. F., Gruzelier, J., & LaVaque, T. J. (2005). Electroencephalographic biofeedback in the treatment of attention-deficit/hyperactivity disorder. Applied Psychophysiology and Biofeedback, 30, 95-114. http://dx.doi.org/ 10.1007/s10484-005-4305-x.
[5]	Monastra VJ. (2005). Electroencephalographic biofeedback (neurotherapy) as a treatment for attention deficit hyperactivity disorder: rationale and empirical foundation. Child & Adolescent Psychiatric Clinics of North America, 14, 55-82. http://dx.doi.org/ 10.1016/j.chc.2004.07.004.
[6]	Myer, N. M., Boland, J. R., & Faraone, S. V. (2017). Pharmacogenetics predictors of methylphenidate efficacy in childhood ADHD. Mol Psychiatry.. doi: 10.1038/mp.2017.234.
[7]	Mehta; M. A; Goodyer, I. M, & Sahakian B. J. (2004). Methylphenidate improves working memory and set-shifting in AD/HD: relationships to baseline memory capacity. J Child Psychol Psychiatry. 2004 Feb; 45(2): 293-305.
[8]	Kidwell, K. M., Van Dyk, T. R., Lundahl, A. & Nelson, T. D. (2015). Stimulant Medications and Sleep for Youth With ADHD: A Meta-analysis. Pediatrics, Dec; 136(6): 1144-53. doi: 10.1542/peds.2015-1708.
[9]	Barkley, R. A., Fischer, M., Fletcher, K., & Smallish, L. (2004). Young adult follow-up of hyperactive children: antisocial activities and drug use. Journal of Child Psychology and Psychiatry, http://dx.doi.org/45, 195–211. 10.1111/j.1469-7610.2004.00214.x.
[10]	Hammond, D. C. (2011). What is neurofeedback: An update. Journal of Neurotherapy: Investigations in Neuromodulation, Neurofeedback and Applied Neuroscience, 15, 305–336. http://dx.doi.org/10.1080/10874208.2011.623090.
[11]	Lubar, J. F. (1997). Neocortial Dynamics: Implications for Understanding the Role of Neurofeedback and Related Techniques for the Enhancement of Attention. Applied Psychophysiology and Biofeedback, 22, 111-126. http://dx.doi.org/10.1023 /A: 1026276228832.
[12]	Arns, M., de Ridder, S., Strehl, U., Breteler, M., & Coenen, A. (2009). Efficacy of neurofeedback treatment in ADHD: the effects on inattention, impulsivity and hyperactivity: a meta-analysis. Clinical EEG and Neuroscience, 40, 180-189. http://dx.doi.org/ 10.1177/155005940904000311.
[13]	Magee, C. A., Clarke, A. R., Barry, R. J., McCarthy, R., & Selikowitz, M. (2005). Examining the diagnostic utility of EEG power measures in children with attention deficit/hyperactivity disorder. Clinical Neurophysiology, 116, 1033-1040. http://dx.doi.org/ 10.1016/j.clinph.2004.12.007.
[14]	Rossiter, T. (2004). The effectiveness of neurofeedback and stimulant drugs in treating AD/HD: Part I. Review of methodological issues. Applied Psychophysiology and Biofeedback, 29, 95-112. http://dx.doi.org/10.1007/s10484-004-0383-4.
[15]	Bluschke, A., Broschwitz, F., Kohl, S., Roessner, V., & Beste, C. (2016). The neuronal mechanisms underlying improvement of impulsivity in ADHD by theta/beta neurofeedback. Sci Rep.; 6: 31178. doi: 10.1038/srep31178.
[16]	Beauregard, M., & Lévesque, J. (2006). Functional magnetic resonance imaging investigation of the effects of neurofeedback training on the neural bases of selective attention and response inhibition in children with attention-deficit/hyperactivity disorder. Applied Psychophysiology and Biofeedback. http://dx.doi.org/10.1007/s10484-006-9001-y.
[17]	Fuchs, T., Birbaumer, N., Lutzenberger, W., Gruzelier, J. H., & Kaiser, J. (2003). Neurofeedback treatment for attention-deficit/hyperactivity disorder in children: a comparison with methylphenidate. Applied Psychophysiology and Biofeedback, 28, 1-12. http://dx.doi.org/10.1023/A: 1022353731579.
[18]	Kropotov, J. D., Grin-Yatsenko, V. A., Ponomarev, V. A., Chutko, L. S., Yakovenko, E. A., & Nikishena, I. S. (2005). ERPs correlates of EEG relative beta training in ADHD children. International Journal of Psychophysiology, 55, 23-34. http://dx.doi.org/10.1016/j.ijpsycho.2004.05.011.
[19]	Lubar, J. F., Swartwood, M. O., Swartwood, J. N., & O'Donnell, P. H. (1995). Evaluation of the effectiveness of EEG neurofeedback training for ADHD in a clinical setting as measured by changes in T. O. V. A. scores, behavioral ratings, and WISC-R performance. Biofeedback and Self Regulation, 20, 83-99. http://dx.doi.org/10.1007/BF01712768.
[20]	Nash, J. K. (2000). Treatment of attention deficit hyperactivity disorder with neurotherapy. Clinical EEG, 31, 30-37. http://dx.doi.org/10.1023/A: 1022353731579.
[21]	Thompson, M., Thompson, L. (1998). Neurofeedback combined with training in metacognitive strategies: effectiveness in students with ADD. Applied Psychophysiology and Biofeedback, 23, 243-263. http://dx.doi.org/10.1023/A: 1022213731956.
[22]	Fahimi, G., Tabatabaei, S. M., Fahimi, E., & Rajebi, H. (2017). Index of Theta/Alpha Ratio of the Quantitative Electroencephalogram in Alzheimer's Disease: A Case-Control Study. Acta Med Iran; 55(8): 502-506.
[23]	Garn, H., Coronel, C., Waser, M., Caravias, G., & Ransmayr, G. (2017). Differential diagnosis between patients with probable Alzheimer's disease, Parkinson's disease dementia, or dementia with Lewy bodies and frontotemporal dementia, behavioral variant, using quantitative electroencephalographic features. J Neural Transm (Vienna) ; 124(5): 569-581. doi: 10.1007/s00702-017-1699-6.
[24]	Haghighi, M., Ludyga, S., Rahimi, B., Jahangard, L., Ahmadpanah, M., Torabian, S.,…& Brand, S. (2017). In patients suffering from major depressive disorders, quantitative EEG showed favorable changes in left and right prefrontal cortex. Psychiatry Res.; 251: 137-141. doi: 10.1016/j.psychres. 2017.02.012.
[25]	Khaleghi, A., Sheikhani, A., Mohammadi, M. R., & Moti Nasrabadi, A. (2015). Evaluation of Cerebral Cortex Function in Clients with Bipolar Mood Disorder I (BMD I) Compared With BMD II Using QEEG Analysis. Iran J Psychiatry; 10(2): 93-9.
[26]	Thatcher, R. W. (2000). EEG operant conditioning (biofeedback) and traumatic brain injury. Clin Electroencephalogr; 31(1): 38-44.
[27]	Arns, M., Peters, S., Breteler, R., & Verhoeven, L. (2007). Different brain activation patterns in dyslexic children: evidence from EEG power and coherence patterns for the double-deficit theory of dyslexia. J Integr Neurosci; 6(1): 175-90.
[28]	Clarke, A. R., Barry, R. J., McCarthy, R., & Selikowitz, M. (2001). Age and sex effects in the EEG: differences in two subtypes of attention-deficit/hyperactivity. Clinical Neurophysiology. http://dx.doi.org/112, 815-826. 10.1016/S1388-2457(01)00487-4.
[29]	Clarke, A. R., Barry, R. J., McCarthy, R., & Selikowitz, M. (2001b). Electroencephalogram differences in two subtypes of attention-deficit/hyperactivity disorder. Psychophysiology, 38, 212-221. http://dx.doi.org/10.1111/1469-8986.3820212.
[30]	Clarke, A. R., Barry, R. J., McCarthy, R., & Selikowitz, M. (2001c). Excess beta activity in children with attention-deficit/hyperactivity disorder: an atypical electrophysiological group. Psychiatry Research, 103, 205-218. http://dx.doi.org/10.1016/S0165-1781(01)00277-3.
[31]	Clarke, A. R., Barry, R. J., McCarthy, R., & Selikowitz, M. (2001d). EEG-defined subtypes of children with attention-deficit/hyperactivity disorder. Clinical Neurophysiology, 112, 2098-2105. http://dx.doi.org/10.1016/S1388-2457(01)00668-X.
[32]	Clarke, A. R., Barry, R. J., McCarthy, R., Selikowitz, M., & Brown, C. R. (2002). EEG evidence for a new conceptualization of attention deficit hyperactivity disorder. Clinical Neurophysiology, 113, 1036-1044. http://dx.doi.org/10.1016/S1388-2457(02)00115-3.
[33]	Lazzaro, I., Gordon, E., & Whitmont, S. (2000). Quantified EEG activity in adolescent attention deficit hyperactivity disorder. Clinical EEG, 29, 37-42. http://dx.doi.org/ 10.1177/155005949802900111.
[34]	Hobbs, M. J., Clarke, A. R., Barry, R. J., McCarthy, R., & Selikowitz, M. (2007). EEG abnormalities in adolescent males with AD/HD. Clinical Neurophysiology, 118, 363-371. http://dx.doi.org/10.1016/j.clinph. 2006.10.013.
[35]	Linden, M., Habib, T., & Radojevic, V. (1996). A controlled study of the effects of EEG biofeedback on cognition and behavior of children with attention deficit disorder and learning disabilities. Biofeedback and Self Regulation, 21, 35-49. http://dx.doi.org/ 10.1007/BF02214740.
[36]	Fuggetta, G., Bennett, M. A., Duke, P. A., & Young, A. M. (2014). Quantitative electroencephalography as a biomarker for proneness toward developing psychosis. Schizophr Res.; 153(1-3): 68-77. doi: 10.1016/j.schres. 2014.01.021.
[37]	Barry, R. J., Johnstone, S. J., & Clarke, A. R. (2003). A review of electrophysiology in attention-deficit/hyperactivity disorder: II. Event-related potentials. Clinical Neurophysiology, 114, 184-198. http://dx.doi.org/10.1016/S1388-2457(02)00362-0.
[38]	Vernon, D., Egner, T., Cooper, N., Compton, T., Neilands, C., Sheri, A., & Gruzelier, J. (2003). The effect of training distinct neurofeedback protocols on aspects of cognitive performance. International Journal of Psychophysiology, 47, 75-85. http://dx.doi.org/ 10.1016/S0167-8760(02)00091-0.
[39]	Mann, C., Lubar, J. F., Zimmerman, A. W., Millar, C. A., & Muenchen, R. A. (1992). Quantitative analysis of EEG in boys with attention deficit-hyperactivity. disorder: Controlled study with clinical applications. Pediatriatric Neurology, 8, 30-36. http://dx.doi.org/10.1007/s13311-012-0131-z.
[40]	Zhang, D. W., Roodenrys, S., Li, H., Barry, R. J., Clarke, AR.., Wu, Z.,…, & Sun, L, (2017). Atypical interference control in children with AD/HD with elevated theta/ beta ratio. Biol Psychol.; 128: 82-88. doi: 10.1016/j.biopsycho. 2017.07.009.
[41]	Loo, S. K., & Scott, M. (2012). Clinical Utility of EEG in Attention-Deficit/Hyperactivity Disorder: A Research Update. Neurotherapeutics; 9(3): 569–587.doi: 10.1007/s13311-012-0131-z.
[42]	Barry, R. J., Clarke, A. R., Hajos, M., Dupuy, F. E., McCarthy, R., & Selikowitz, M. (2011). EEG coherence and symptom profiles of children with Attention-Deficit/Hyperactivity Disorder. Clinical Neurophysiology, 122, 1327-1332. http://dx.doi.org/ 10.1016/j.clinph. 2006.10.002.
[43]	Barry, R. J., & Clarke, A. R. (2013). Resting state brain oscillations and symptom profiles in attention deficit/hyperactivity disorder. Suppl Clin Neurophysiol.; 62: 275-87.
[44]	Kröger, A., Hof, K., Krick, C., Siniatchkin, M., Jarczok, T., Freitag, C. M,, & Bender, S. (2014). Visual Processing of Biological Motion in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: An Event Related Potential-Study. PLoS One.; 9(2): e88585. doi: 10.1371/journal.pone.0088585.
[45]	Gioia, G. A., Isquith, P. K., Guy, S. C, & Kenworthy, L. (2000). Behavior Rating Inventory of Executive Function (BRIEF). Child Neuropsychology, 6, 235-238. http://dx.doi.org/10.1076/chin.6.3.235.3152.
[46]	Conners, C. (2007). The Conners, 3rd Edition™. Pearson. Us.
[47]	Greenberg, L. M., Kindschi, C. L., & Corman, C. M. (2000). T. O. V. A. test of variables of attention. Clinical Guide. Copyright Universal Attention Disorders.
[48]	Duarte. E., González Marques, J., & Alvarado, J. M. (2017). Effect of the Theta-Beta Neurofeedback Protocol as a Function of Subtype in Children Diagnosed with Attention Deficit Hyperactivity Disorder. The Spanish Journal of Psychology 2017 \| journal-article. DOI: 10.1017/sjp.2016.31.
[49]	Egner, T., & Gruzelier, J. H. (2001). Learned self-regulation of EEG frequency components affects attention and event-related brain potentials in humans. Neuroreport, 21, 4155-4159. http://dx.doi.org/10.1097/00001756-200112210-00058.
[50]	Egner, T., & Gruzelier, J. H. (2004). EEG biofeedback of low beta band components: frequency-specific effects on variables of attention and event-related brain potentials. Clinical Neurophysiology, 115, 131-139. http://dx.doi.org/10.1016/S1388-2457(03)00353-5.
[51]	Arns, M., Heinrich, H., & Strehl, U. (2014). Evaluation of neurofeedback in ADHD: the long and winding road. Biol Psychol.; 95: 108-15. doi: 10.1016/j.biopsycho. 2013.11.013.
[52]	deBeus, R. J., & Kaiser, D. A. (2011). Neurofeedback with Children with Attentin Deficit Hyperactivity Disorder: A randomized Double-Blind Placebo-Controlled Study. Neurofeedback and Neuromodulation Techniques and Applications. Elsevier, 127-153. http://dx.doi.org/10.1007/s00702-010-0524-2.

Cite This Article

Plain Text BibTeX RIS

APA Style

Denise Medici, Pau Giner Bayarri, Rosa Chilet Chilet, Juan Moliner Ibánez, Maria Morales Suarez-Varela, et al. (2018). Neurofeedback Versus Pharmacological Intervention in the Treatment of Childhood Attention Deficit/Hyperactivity Disorder (ADHD): First Spanish Clinical Neuropsychological Study. American Journal of Applied Psychology, 7(5), 57-66. https://doi.org/10.11648/j.ajap.20180705.11

Copy | Download

ACS Style

Denise Medici; Pau Giner Bayarri; Rosa Chilet Chilet; Juan Moliner Ibánez; Maria Morales Suarez-Varela, et al. Neurofeedback Versus Pharmacological Intervention in the Treatment of Childhood Attention Deficit/Hyperactivity Disorder (ADHD): First Spanish Clinical Neuropsychological Study. Am. J. Appl. Psychol. 2018, 7(5), 57-66. doi: 10.11648/j.ajap.20180705.11

Copy | Download

AMA Style

Denise Medici, Pau Giner Bayarri, Rosa Chilet Chilet, Juan Moliner Ibánez, Maria Morales Suarez-Varela, et al. Neurofeedback Versus Pharmacological Intervention in the Treatment of Childhood Attention Deficit/Hyperactivity Disorder (ADHD): First Spanish Clinical Neuropsychological Study. Am J Appl Psychol. 2018;7(5):57-66. doi: 10.11648/j.ajap.20180705.11

Copy | Download

@article{10.11648/j.ajap.20180705.11,
  author = {Denise Medici and Pau Giner Bayarri and Rosa Chilet Chilet and Juan Moliner Ibánez and Maria Morales Suarez-Varela and Dayana Calvo},
  title = {Neurofeedback Versus Pharmacological Intervention in the Treatment of Childhood Attention Deficit/Hyperactivity Disorder (ADHD): First Spanish Clinical Neuropsychological Study},
  journal = {American Journal of Applied Psychology},
  volume = {7},
  number = {5},
  pages = {57-66},
  doi = {10.11648/j.ajap.20180705.11},
  url = {https://doi.org/10.11648/j.ajap.20180705.11},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajap.20180705.11},
  abstract = {In this study, twenty children diagnosed with ADHD according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria (DSM-IV) were randomly assigned to receive NFB training or MPH treatment. The participants were evaluated at the beginning of the study and four months later on measures of behavioral (CPRS/CPRT), executive functions (BRIEF, CPT), attention (TOVA), and electrical activity (qEEG, ERPs). Post-intervention results showed improvements in attention, hyperactivity, executive functioning and in continuous performance measurement (CPT).Improvements noted in the NFB group were greater than that of the MPH group. Results of this study suggest NFB training resulted in greater improvements in executive functioning, behavior, attention, and qEEG compared to MPH treatment. Results indicate that neurofeedback may treatcognitive and behavior functions before these functions worsen or decrease. This study suggests future research to compare the efficacy of each of these treatments in larger populations with a greater heterogeneity in gender is warranted.},
 year = {2018}
}

Copy | Download

TY  - JOUR
T1  - Neurofeedback Versus Pharmacological Intervention in the Treatment of Childhood Attention Deficit/Hyperactivity Disorder (ADHD): First Spanish Clinical Neuropsychological Study
AU  - Denise Medici
AU  - Pau Giner Bayarri
AU  - Rosa Chilet Chilet
AU  - Juan Moliner Ibánez
AU  - Maria Morales Suarez-Varela
AU  - Dayana Calvo
Y1  - 2018/12/18
PY  - 2018
N1  - https://doi.org/10.11648/j.ajap.20180705.11
DO  - 10.11648/j.ajap.20180705.11
T2  - American Journal of Applied Psychology
JF  - American Journal of Applied Psychology
JO  - American Journal of Applied Psychology
SP  - 57
EP  - 66
PB  - Science Publishing Group
SN  - 2328-5672
UR  - https://doi.org/10.11648/j.ajap.20180705.11
AB  - In this study, twenty children diagnosed with ADHD according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria (DSM-IV) were randomly assigned to receive NFB training or MPH treatment. The participants were evaluated at the beginning of the study and four months later on measures of behavioral (CPRS/CPRT), executive functions (BRIEF, CPT), attention (TOVA), and electrical activity (qEEG, ERPs). Post-intervention results showed improvements in attention, hyperactivity, executive functioning and in continuous performance measurement (CPT).Improvements noted in the NFB group were greater than that of the MPH group. Results of this study suggest NFB training resulted in greater improvements in executive functioning, behavior, attention, and qEEG compared to MPH treatment. Results indicate that neurofeedback may treatcognitive and behavior functions before these functions worsen or decrease. This study suggests future research to compare the efficacy of each of these treatments in larger populations with a greater heterogeneity in gender is warranted.
VL  - 7
IS  - 5
ER  -

Copy | Download

Author Information

Denise Medici

Department of Preventive Medicine, University of Valencia, Valencia, Spain; Department of Neuropsychology, Hospital Vithas Nisa 9 de Octubre, Valencia, Spain
Pau Giner Bayarri

Department of Neurophysiology, Hospital Universitario Dr. Peset, Valencia, Spain
Rosa Chilet Chilet

Department of Neurophysiology, Hospital Universitario Dr. Peset, Valencia, Spain
Juan Moliner Ibánez

Department of Neurophysiology, Hospital Universitario Dr. Peset, Valencia, Spain
Maria Morales Suarez-Varela

Department of Preventive Medicine, University of Valencia, Valencia, Spain; Department of Biomedical Research Consortium for Epidemiology and Public Health (CIBERESP), Valencia, Spain; Center for Public Health Research (CSISP), Valencia, Spain
Dayana Calvo

Department of Neuropsychology, James A. Haley Veteran’s Hospital, Tampa, USA

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Denise Medici, Pau Giner Bayarri, Rosa Chilet Chilet, Juan Moliner Ibánez, Maria Morales Suarez-Varela, et al. (2018). Neurofeedback Versus Pharmacological Intervention in the Treatment of Childhood Attention Deficit/Hyperactivity Disorder (ADHD): First Spanish Clinical Neuropsychological Study. American Journal of Applied Psychology, 7(5), 57-66. https://doi.org/10.11648/j.ajap.20180705.11

Copy | Download

ACS Style

Denise Medici; Pau Giner Bayarri; Rosa Chilet Chilet; Juan Moliner Ibánez; Maria Morales Suarez-Varela, et al. Neurofeedback Versus Pharmacological Intervention in the Treatment of Childhood Attention Deficit/Hyperactivity Disorder (ADHD): First Spanish Clinical Neuropsychological Study. Am. J. Appl. Psychol. 2018, 7(5), 57-66. doi: 10.11648/j.ajap.20180705.11

Copy | Download

AMA Style

Denise Medici, Pau Giner Bayarri, Rosa Chilet Chilet, Juan Moliner Ibánez, Maria Morales Suarez-Varela, et al. Neurofeedback Versus Pharmacological Intervention in the Treatment of Childhood Attention Deficit/Hyperactivity Disorder (ADHD): First Spanish Clinical Neuropsychological Study. Am J Appl Psychol. 2018;7(5):57-66. doi: 10.11648/j.ajap.20180705.11

Copy | Download

@article{10.11648/j.ajap.20180705.11,
  author = {Denise Medici and Pau Giner Bayarri and Rosa Chilet Chilet and Juan Moliner Ibánez and Maria Morales Suarez-Varela and Dayana Calvo},
  title = {Neurofeedback Versus Pharmacological Intervention in the Treatment of Childhood Attention Deficit/Hyperactivity Disorder (ADHD): First Spanish Clinical Neuropsychological Study},
  journal = {American Journal of Applied Psychology},
  volume = {7},
  number = {5},
  pages = {57-66},
  doi = {10.11648/j.ajap.20180705.11},
  url = {https://doi.org/10.11648/j.ajap.20180705.11},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajap.20180705.11},
  abstract = {In this study, twenty children diagnosed with ADHD according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria (DSM-IV) were randomly assigned to receive NFB training or MPH treatment. The participants were evaluated at the beginning of the study and four months later on measures of behavioral (CPRS/CPRT), executive functions (BRIEF, CPT), attention (TOVA), and electrical activity (qEEG, ERPs). Post-intervention results showed improvements in attention, hyperactivity, executive functioning and in continuous performance measurement (CPT).Improvements noted in the NFB group were greater than that of the MPH group. Results of this study suggest NFB training resulted in greater improvements in executive functioning, behavior, attention, and qEEG compared to MPH treatment. Results indicate that neurofeedback may treatcognitive and behavior functions before these functions worsen or decrease. This study suggests future research to compare the efficacy of each of these treatments in larger populations with a greater heterogeneity in gender is warranted.},
 year = {2018}
}

Copy | Download

TY  - JOUR
T1  - Neurofeedback Versus Pharmacological Intervention in the Treatment of Childhood Attention Deficit/Hyperactivity Disorder (ADHD): First Spanish Clinical Neuropsychological Study
AU  - Denise Medici
AU  - Pau Giner Bayarri
AU  - Rosa Chilet Chilet
AU  - Juan Moliner Ibánez
AU  - Maria Morales Suarez-Varela
AU  - Dayana Calvo
Y1  - 2018/12/18
PY  - 2018
N1  - https://doi.org/10.11648/j.ajap.20180705.11
DO  - 10.11648/j.ajap.20180705.11
T2  - American Journal of Applied Psychology
JF  - American Journal of Applied Psychology
JO  - American Journal of Applied Psychology
SP  - 57
EP  - 66
PB  - Science Publishing Group
SN  - 2328-5672
UR  - https://doi.org/10.11648/j.ajap.20180705.11
AB  - In this study, twenty children diagnosed with ADHD according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria (DSM-IV) were randomly assigned to receive NFB training or MPH treatment. The participants were evaluated at the beginning of the study and four months later on measures of behavioral (CPRS/CPRT), executive functions (BRIEF, CPT), attention (TOVA), and electrical activity (qEEG, ERPs). Post-intervention results showed improvements in attention, hyperactivity, executive functioning and in continuous performance measurement (CPT).Improvements noted in the NFB group were greater than that of the MPH group. Results of this study suggest NFB training resulted in greater improvements in executive functioning, behavior, attention, and qEEG compared to MPH treatment. Results indicate that neurofeedback may treatcognitive and behavior functions before these functions worsen or decrease. This study suggests future research to compare the efficacy of each of these treatments in larger populations with a greater heterogeneity in gender is warranted.
VL  - 7
IS  - 5
ER  -

Copy | Download